Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company
Start price
02.08.24
/
50%
€46.20
Target price
02.08.25
€68.71
Performance (%)
-46.75%
End price
03.08.25
€24.60
Summary
This prediction ended on 03.08.25 with a price of €24.60. Massive losses of -46.75% were the result for the BUY prediction by Wells_Fargo___Compan. Wells_Fargo___Compan has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.970% | 2.970% | -52.074% |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Wells Fargo & Company from $72.00 to $75.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€26.00
10.07.25
10.07.25
€55.35
10.07.26
10.07.26
-22.31%
09:46
09:46
Stopped prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€17.00
30.12.25
30.12.25
€38.21
30.12.26
30.12.26
18.82%
09:46
09:46
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€29.20
20.10.25
20.10.25
€55.74
20.10.26
20.10.26
-30.82%
09:46
09:46
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.80
20.12.24
20.12.24
€84.54
20.12.25
20.12.25
-32.06%
21.12.25
21.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€37.60
08.12.23
08.12.23
€66.97
08.12.24
08.12.24
23.94%
09.12.24
09.12.24

